Stockscreener 앱 받기
37.47
3.00%
-1.16
시간 외 거래:
37.60
0.13
+0.35%
전일 마감가:
$38.63
열려 있는:
$38.19
하루 거래량:
3.17M
Relative Volume:
1.25
시가총액:
$7.05B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
37.47
EPS:
1
순현금흐름:
$232.07M
1주 성능:
-7.78%
1개월 성능:
-15.95%
6개월 성능:
-36.33%
1년 성능:
-36.46%
1일 변동 폭
$37.35
$38.79
1주일 범위
$37.33
$41.12
52주 변동 폭
$37.33
$85.21
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
37.47 | 7.27B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
203.92 | 34.52B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
59.82 | 11.30B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
85.67 | 7.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.27 | 7.18B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
BofA Securities lowers Doximity stock price target to $70 from $82 - Investing.com Nigeria
TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom? - Prime Publishers, Inc.
Doximity (NASDAQ:DOCS) Reaches New 1-Year LowShould You Sell? - MarketBeat
Is It Time To Reassess Doximity (DOCS) After Its Recent Share Price Slide? - Yahoo Finance
Is Doximity (DOCS) Trading Medicare Resilience For A Slower, Narrower Platform Growth Story? - Yahoo Finance
Doximity stock hits 52-week low at $38.75 amid challenging year - Investing.com Nigeria
Why Doximity (DOCS) is a Top Growth Stock for the Long-Term - Yahoo Finance
Doximity (NYSE:DOCS) Upgraded at Zacks Research - MarketBeat
Doximity (DOCS) Stock Dips While Market Gains: Key Facts - Yahoo Finance Singapore
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
What Makes Doximity (DOCS) a New Strong Buy Stock - Yahoo Finance
Doximity (DOCS) Fell as Guidance Fell Short of Expectations - Insider Monkey
Assessing Doximity (DOCS) Valuation After Cautious Earnings Guidance And Guarded Investor Sentiment - Yahoo Finance
Institutional Sentiment Shifts As Doximity Balances Guidance And Growth Story - Sahm
Baillie Gifford & Co. Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
Should Doximity's Expanding Digital Health Platform Reframe the Core Investment Narrative for DOCS? - Sahm
OpenEvidence, Doximity Advance Dispute Over AI Platform Access - Bloomberg Law News
Insider Trends: What is the cash position of Doximity IncTrade Risk Report & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Overweight Doximity (DOCS) Position Weighs on Fund Performance - Insider Monkey
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Aubrey Capital Management Ltd Purchases Shares of 62,500 Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Hits New 12-Month LowHere's What Happened - MarketBeat
Doximity stock hits 52-week low at $39.92 amid challenging year - Investing.com Nigeria
Doximity stock hits 52-week low at $39.92 amid challenging year By Investing.com - Investing.com India
Wells Fargo & Company Upgrades Doximity (NYSE:DOCS) to Strong-Buy - MarketBeat
DOCS Analyst Rating Update: Wells Fargo Lowers Price Target | DO - GuruFocus
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Assessing Doximity: Insights From 9 Financial Analysts - Benzinga
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - 24/7 Wall St.
Morgan Stanley views Doximity (DOCS) underperformance as attractive entry point amid strong engagement - MSN
Is It Time To Reconsider Doximity (DOCS) After Recent Share Price Weakness - Sahm
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026 - 01net
Raymond James Sees 'Knee-Jerk' AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Finviz
Doximity (DOCS) Is Down 13.4% After Cutting 2026 Revenue Outlook Amid Regulatory PressuresWhat's Changed - Sahm
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Insider Monkey
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Bandwidth, Dynatrace, Paylocity, Doximity, and Agilysys Stocks Trade Down, What You Need To Know - The Globe and Mail
RSI Alert: Doximity (DOCS) Now Oversold - Nasdaq
Redlands Daily Facts - FinancialContent
Is Doximity (DOCS) Pricing Reflect Its Mixed Valuation Signals After Recent Share Price Slide - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - sharewise.com
Doximity (DOCS) declines more than market: Some information for investors - MSN
Winners Losers: Will Doximity Inc stock reach Wall Street targetsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Doximity (NASDAQ:DOCS) Sets New 1-Year LowWhat's Next? - MarketBeat
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.41%
2.51%
자본화:
|
볼륨(24시간):